[1]
“ADVANCES IN TRANSDERMAL DELIVERY OF ZOLMITRIPTAN AND FROVATRIPTAN: PHARMACOLOGY, THERAPEUTIC CHALLENGES, AND INNOVATIVE STRATEGIES”, JMHSR, vol. 2, no. 4, Dec. 2025, doi: 10.65035/3tk2k466.